» Articles » PMID: 37595343

Sociodemographic Disparities in ADHD Diagnosis and Treatment Among U.S. Elementary Schoolchildren

Overview
Journal Psychiatry Res
Specialty Psychiatry
Date 2023 Aug 18
PMID 37595343
Authors
Affiliations
Soon will be listed here.
Abstract

We examined whether some groups of U.S. elementary schoolchildren are less likely to be diagnosed and treated for ADHD in analyses of a population-based cohort (N = 10,920). We predicted ADHD diagnosis using measures of race and ethnicity, age, socioeconomic status, birthweight, individually assessed academic, behavioral, and executive functioning, family language use, mental health, health insurance coverage, marital status, school composition, and geographic region. We predicted prescription medication use among those diagnosed with ADHD. We stratified additional analyses by biological sex. Black children (aOR, 0.60), girls (aOR, 0.55), and emergent bilinguals (aOR, 0.29) were less likely to have an ADHD diagnosis than observationally similar White children, boys, or those from English-speaking households. Black children's under-diagnosis occurred among boys. Emergent bilingual children's under-diagnosis occurred among both boys and girls. Girls (aOR, 0.52) and emergent bilinguals (aOR, 0.24) with ADHD were less likely to use prescription medication. Sociodemographic disparities in ADHD diagnosis and treatment occur among U.S. elementary schoolchildren. Measured confounds including independently assessed ADHD symptomatology and impairment do not explain the disparities. The findings empirically support cultural, linguistic, and biological sensitivity in the ADHD diagnostic and treatment procedures in use for the U.S. pediatric population.

Citing Articles

Examining the Association Between Adverse Childhood Experiences and ADHD in School-Aged Children Following the COVID-19 Pandemic.

Boswell E, Crouch E, Odahowski C, Hung P J Atten Disord. 2024; 29(1):42-52.

PMID: 39422221 PMC: 11585178. DOI: 10.1177/10870547241290673.


ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment.

Danielson M, Claussen A, Bitsko R, Katz S, Newsome K, Blumberg S J Clin Child Adolesc Psychol. 2024; 53(3):343-360.

PMID: 38778436 PMC: 11334226. DOI: 10.1080/15374416.2024.2335625.

References
1.
Danielson M, Holbrook J, Bitsko R, Newsome K, Charania S, McCord R . State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019. J Atten Disord. 2022; 26(13):1685-1697. PMC: 9489617. DOI: 10.1177/10870547221099961. View

2.
Mowlem F, Rosenqvist M, Martin J, Lichtenstein P, Asherson P, Larsson H . Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry. 2018; 28(4):481-489. PMC: 6445815. DOI: 10.1007/s00787-018-1211-3. View

3.
Beck D, Schaefer C, Pang K, Carlson S . Executive Function in Preschool Children: Test-Retest Reliability. J Cogn Dev. 2011; 12(2):169-193. PMC: 3105625. DOI: 10.1080/15248372.2011.563485. View

4.
Zuckerman K, Mattox K, Sinche B, Blaschke G, Bethell C . Racial, ethnic, and language disparities in early childhood developmental/behavioral evaluations: a narrative review. Clin Pediatr (Phila). 2013; 53(7):619-31. PMC: 3955219. DOI: 10.1177/0009922813501378. View

5.
Miller T, Nigg J, Miller R . Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?. Clin Psychol Rev. 2008; 29(1):77-86. PMC: 4301609. DOI: 10.1016/j.cpr.2008.10.001. View